Buscar
01/05/2023
Experimental validation of seminal miR-31-5p as biomarker for azoospermia and evaluation of the effect of preanalytical variables
Plata-Pena, L, Lopez-Rodrigo, O, Bassas, L, Larriba, S. Experimental validation of seminal miR-31-5p as biomarker for azoospermia and evaluation of the effect of preanalytical variables. Andrology. 2023; 11(4)DOI:10.1111/andr.13286. PMID:36057114. IF:3.200(Q1/3D).
01/05/2023
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
Velleca, A, Shullo, MA, Dhital, K, Azeka, E, Colvin, M, DePasquale, E, Farrero, M, Garcia-Guereta, L, Jamero, G, Khush, K, Lavee, J, Pouch, S, Patel, J, Michaud, CJ, Schubert, S, Angelini, A, Carlos, L, Mirabet, S, Pham, M, Urschel, S, Kim, KH, Miyamoto, S, Chih, SR, Daly, K, Grossi, P, Jennings, DL, Kim, IC, Lim, HS, Miller, T, Potena, L, Eisen, H, Bellumkonda, L, Danziger-Isakov, L, Dobbels, F, Harkess, M, Kim, D, Lyster, H, Peled, Y, Reinhardt, Z. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2023; 42(5)DOI:10.1016/j.healun.2022.10.015. PMID:37080658. IF:6.400(Q1/1D).
01/05/2023
Blood pool in a patient with intramural aortic hematoma
Molina, JM, Munoz, JD. Blood pool in a patient with intramural aortic hematoma. Angiologia. 2023; 75(3)DOI:10.20960/angiologia.00492. PMID:. IF:(Q/D).
01/05/2023
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
Miarons, M, Gordon, AM, Riera, P, Nicolas, FG. Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study. ONCOLOGIST. 2023; 28(5)DOI:10.1093/oncolo/oyad077. PMID:37014829. IF:4.800(Q1/3D).
01/05/2023
Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5)DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3.100(Q2/5D).
01/05/2023
Research Priorities for Precision Medicine in NAFLD
Iruzubieta, P, Bataller, R, Arias-Loste, MT, Arrese, M, Calleja, JL, Castro-Narro, G, Cusi, K, Dillon, JF, Martinez-Chantar, ML, Mateo, M, Perez, A, Rinella, ME, Romero-Gomez, M, Schattenberg, JM, Zelber-Sagi, S, Crespo, J, Lazarus, JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2)DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2.900(Q2/5D).
01/05/2023
The Good Life From Birth to Death
Paff, SM, Olives, MG, Zaragoza, BC, Porcel, MA, Fernandez, AR, Serret, MS, Abal, ER. The Good Life From Birth to Death. Holistic Nursing Practice. 2023; 37(3)DOI:10.1097/HNP.0000000000000582. PMID:37070837. IF:1.300(Q3/6D).
01/05/2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J, Besse, B, Aix, SP, Callejo, A, Al-Rabi, K, Bernabe, R, Greillier, L, Majem, M, Reguart, N, Monnet, I, Cousin, S, Garrido, P, Robinet, G, Campelo, RG, Madroszyk, A, Mazieres, J, Curcio, H, Wasag, B, Pretzenbacher, Y, Fournier, B, Dingemans, AMC, Dziadziuszko, R. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial. ANNALS OF ONCOLOGY. 2023; 34(5)DOI:10.1016/j.annonc.2023.02.012. PMID:36863484. IF:56.700(Q1/1D).